Reply.
作者信息
Singal Amit G, Daher Darine, Seif El Dahan Karim, Rich Nicole E, Yang Ju Dong, Parikh Neehar D
机构信息
Department of Internal Medicine, UT Southwestern Medical Center, Dallas, Texas.
Department of Internal Medicine, Cedars Sinai Medical Center, Los Angeles, California.
出版信息
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1340-1341. doi: 10.1016/j.cgh.2023.10.032. Epub 2023 Nov 17.
Abstract
摘要
相似文献
1
Reply.回复。
Clin Gastroenterol Hepatol. 2024 Jun;22(6):1340-1341. doi: 10.1016/j.cgh.2023.10.032. Epub 2023 Nov 17.
2
Reply networks on a bulletin board system.公告板系统上的回复网络。
Phys Rev E Stat Nonlin Soft Matter Phys. 2003 Mar;67(3 Pt 2):036117. doi: 10.1103/PhysRevE.67.036117. Epub 2003 Mar 24.
3
Female reply strategies in a duetting Australian bushcricket, Caedicia sp. (Phaneropterinae: Tettigoniidae: Orthoptera).澳大利亚一种二重唱灌丛蟋蟀Caedicia sp.（扇螽亚科：螽斯科：直翅目）中的雌性回应策略
J Exp Biol. 2004 Feb;207(Pt 5):803-11. doi: 10.1242/jeb.00840.
4
The Effect of Timing of Female Vibrational Reply on Male Signalling and Searching Behaviour in the Leafhopper Aphrodes makarovi.雌性振动回应时间对叶蝉Aphrodes makarovi雄性信号传递和搜索行为的影响
PLoS One. 2015 Oct 21;10(10):e0139020. doi: 10.1371/journal.pone.0139020. eCollection 2015.
5
Quality and general practitioner satisfaction with reply letters for dementia patients.痴呆症患者回信的质量与全科医生满意度
Qual Prim Care. 2008;16(3):165-70.
6
Addressing Antivaccine Sentiment on Public Social Media Forums Through Web-Based Conversations Based on Motivational Interviewing Techniques: Observational Study.通过基于动机访谈技术的网络对话解决公共社交媒体论坛上的反疫苗情绪：观察性研究。
JMIR Infodemiology. 2023 Nov 14;3:e50138. doi: 10.2196/50138.
7
Reply letter utilization by secondary level specialists in a municipality in Brazil: a qualitative study.巴西某城市二级专家回复信的使用情况：一项定性研究
Rev Panam Salud Publica. 2007 Feb-Mar;21(2-3):96-110. doi: 10.1590/s1020-49892007000200005.
8
Training specialists to write appropriate reply letters to general practitioners about patients with medically unexplained physical symptoms; A cluster-randomized trial.培训专家就患有医学上无法解释的身体症状的患者向全科医生撰写恰当的回信；一项整群随机试验。
Patient Educ Couns. 2015 Oct;98(10):1229-35. doi: 10.1016/j.pec.2015.06.021. Epub 2015 Jul 2.
9
What is a low dose? Response to "Reply to 'The RBE of low-LET radiations' " Reply to the Response to "Reply to 'The RBE of low-LET radiations' " Comment on 'Updated estimates of the proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionising radiation' Reply to "Comment on 'Updated estimates of the proportion of childhood leukaemia incidence in Great Britain that may be caused by natural background ionising radiation' ".什么是低剂量？对《对〈低传能线密度辐射的相对生物效应〉的回复》的回复 对《对〈对〈低传能线密度辐射的相对生物效应〉的回复〉的回复》的回应 对《英国儿童白血病发病率中可能由天然本底电离辐射引起的比例的最新估计》的评论 对《对〈英国儿童白血病发病率中可能由天然本底电离辐射引起的比例的最新估计〉的评论》的回复
J Radiol Prot. 2010 Mar;30(1):93-101; author reply 99-101. doi: 10.1088/0952-4746/30/1/L01. Epub 2010 Mar 10.
10
Emoji can facilitate recognition of conveyed indirect meaning.表情符号可以促进对所传达的间接意义的识别。
PLoS One. 2020 Apr 30;15(4):e0232361. doi: 10.1371/journal.pone.0232361. eCollection 2020.
引用本文的文献
1
Proposal of discontinuation criteria of atezolizumab plus bevacizumab after curative conversion therapy for unresectable early-to-intermediate-stage hepatocellular carcinoma: a multicenter proof-of-concept study.不可切除的早中期肝细胞癌根治性转化治疗后阿替利珠单抗联合贝伐单抗停药标准的提议：一项多中心概念验证研究
J Gastroenterol. 2025 Jun;60(6):738-753. doi: 10.1007/s00535-025-02233-z. Epub 2025 Mar 7.
2
Epidemiology, pathophysiology and clinical aspects of Hepatocellular Carcinoma in MAFLD patients.代谢相关脂肪性肝病患者肝细胞癌的流行病学、病理生理学和临床特征。
Hepatol Int. 2024 Oct;18(Suppl 2):922-940. doi: 10.1007/s12072-024-10692-4. Epub 2024 Jul 16.
本文引用的文献
1
Hepatocellular Carcinoma Surveillance Patterns and Outcomes in Patients With Cirrhosis.肝细胞癌监测模式和肝硬化患者的预后。
Clin Gastroenterol Hepatol. 2024 Feb;22(2):295-304.e2. doi: 10.1016/j.cgh.2023.08.003. Epub 2023 Aug 12.
2
Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis.肝硬化患者肝细胞癌筛查的经济负担。
Clin Gastroenterol Hepatol. 2024 Apr;22(4):760-767.e1. doi: 10.1016/j.cgh.2023.07.018. Epub 2023 Aug 5.
3
Hepatocellular carcinoma surveillance may be associated with potential psychological harms in patients with cirrhosis.肝细胞癌监测可能会给肝硬化患者带来潜在的心理伤害。
Hepatology. 2024 Jan 1;79(1):107-117. doi: 10.1097/HEP.0000000000000528. Epub 2023 Jul 4.
4
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
5
Blood-based biomarkers for hepatocellular carcinoma screening: Approaching the end of the ultrasound era?基于血液的肝细胞癌筛查生物标志物：即将结束超声时代？
J Hepatol. 2023 Jan;78(1):207-216. doi: 10.1016/j.jhep.2022.08.036. Epub 2022 Sep 8.
6
HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.HCC 监测可提高肝硬化患者的早期检测、根治性治疗的获得和生存率：一项荟萃分析。
J Hepatol. 2022 Jul;77(1):128-139. doi: 10.1016/j.jhep.2022.01.023. Epub 2022 Feb 6.
7
Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis.患者报告的障碍与肝硬化患者多中心队列中接受肝细胞癌监测的情况相关。
Clin Gastroenterol Hepatol. 2021 May;19(5):987-995.e1. doi: 10.1016/j.cgh.2020.06.049. Epub 2020 Jul 3.
8
Hepatocellular carcinoma tumour volume doubling time: a systematic review and meta-analysis.肝细胞癌肿瘤体积倍增时间：系统评价和荟萃分析。
Gut. 2021 Feb;70(2):401-407. doi: 10.1136/gutjnl-2020-321040. Epub 2020 May 12.
9
Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance.初级保健提供者的实践模式及肝癌监测的障碍。
Clin Gastroenterol Hepatol. 2019 Mar;17(4):766-773. doi: 10.1016/j.cgh.2018.07.029. Epub 2018 Jul 26.
10
Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?开展肝癌筛查随机对照试验的可行性：肝癌筛查的随机对照试验是否可行或仍有必要？
Hepatology. 2011 Dec;54(6):1998-2004. doi: 10.1002/hep.24581.
Zotero 插件